Latest Share Chat

Syncona Share News (SYNC)

Syncona Information

Buy SYNC Shares
Add SYNC to Watchlist
Add SYNC to Alert

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 110.00

Bid: 112.00

Ask: 113.00

Change: -2.40 (-2.14%)

Spread: 1.00 (0.893%)

Open: 112.20

High: 113.60

Low: 110.00

Prev. Close: 112.40

Last checked at -

Syncona is an Investment Trust

To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.

Find out More

IN BRIEF: Syncona investee Achilles Therapeutics files for US IPO

Tue, 02nd Mar 2021 13:45

Syncona Ltd - investor in life science companies - Portfolio firm Achilles Therapeutics PLC files with US Securities & Exchange Commission for a proposed initial public offering of American Depositary Shares. JP Morgan, BofA Securities and Piper Sandler are expected to be book-running managers for the IPO, with Chardan, Oppenheimer & Co and Kempen & Co as co-managers. Syncona says the number ADSs to be sold and the pricing have not yet been set. Achilles is a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumours.

Current stock price: 254.38 pence

Year-to-date change: down 2.5%

By Tom Waite; thomaslwaite@alliancenews.com

More News

23 Jan 2020 09:00

Syncona, Arix Note Pricing Of Public Offering By Autolus Therapeutics

23 Jan 2020 08:14

Syncona puts $15m into Autolus US offering

(Sharecast News) - Healthcare investment company Syncona announced on Thursday that its portfolio company, Autolus Therapeutics, had confirmed the pricing of its underwritten public offering in the United States.

19 Dec 2019 08:58

Syncona Commits USD80 Million Investment Into Freeline Therapeutics

19 Dec 2019 07:53

Syncona commits $80m to Freeline

(Sharecast News) - Healthcare company Syncona said it had made an $80m (£61.1m) funding commitment to biotech company Freeline.

9 Dec 2019 09:32

Syncona upbeat on latest data from Autolus Therapeutics

(Sharecast News) - Syncona shares were just above the waterline on Monday morning, after two updates from its portfolio company Autolus Therapeutics, in which it announced new data at the American Society of Hematology (ASH) annual meeting in Orlando, Florida.

9 Dec 2019 08:31

Syncona And Arix Note Positive New Data From Portfolio Firm Autolus

21 Nov 2019 10:47

Syncona Adds Azeria Therapeutics To Portfolio As Net Assets Take Hit

21 Nov 2019 08:34

Syncona sees negative returns as it continues to invest in portfolio firms

(Sharecast News) - Healthcare investment company Syncona reported net assets of £1.37bn in its interim results on Thursday, down from £1.46bn at the end of the last financial year.

3 Sep 2019 08:18

Syncona Provides GBP83 Million In Funding For Two Portfolio Companies

(Alliance News) - Syncona Ltd said Tuesday it has made investments totalling GBP83.1 million in two companies in separate Series B financing rounds.The FTSE 250 healthcare-focused firm made

3 Sep 2019 07:58

Syncona invests ?83.1m in Gyroscope and Achilles

(Sharecast News) - Syncona on Tuesday confirmed investments of £48.0m in retinal gene therapy group Gyroscope Therapeutic and £35.1m in cancer immunotherapies developer Achilles Therapeutics.

12 Aug 2019 11:45

CORRECT: Syncona Quarterly Net Asset Value Higher On Blue Earth Sale

(Correcting that the net asset value per share as at March 31 was 216.8p, meaning NAV decreased over the course of the quarter.)(Alliance News) - Healthcare investor Syncona Ltd said its in

12 Aug 2019 09:30

Syncona Net Asset Value Lifted In First Quarter By Blue Earth Sale

(Alliance News) - Healthcare investor Syncona Ltd said Thursday its net asset value rose in the first quarter of its financial year, despite a drop in the value of its portfolio due to a declining

9 Aug 2019 16:07

UK Earnings, Trading Statements Calendar - Next 7 Days

Monday 12 August ClarksonHalf Year ResultsSynconaQuarterly 13 Year Year

8 Jul 2019 09:04

Syncona's Freeline Therapeutics Reports Results From Haemophilia Trial

(Alliance News) - Healthcare-focused investment firm Syncona Ltd said Monday that portfolio company Freeline Therapeutics has published 12-month data from an ongoing trial in haemophilia B, and a

27 Jun 2019 09:47

Syncona Disposes Stake In Blue Earth Diagnostics To Bracco Imaging

(Alliance News) - Investment firm Syncona Ltd on Thursday said it has agreed to sell its portfolio company Blue Earth Diagnostics to Bracco Imaging for USD450 million plus closing adjustment at in

Latest Share Chat

Syncona Share News (SYNC)

Share Price Information for Syncona (SYNC)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Syncona investee Achilles Therapeutics files for US IPO

Login to your account

Quickpicks are a member only feature

Login to your account